Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis

Journal of Viral Hepatitis

Volumn 6, Issue 6, 1999, Pages 471-475

  Brojer, E ^a   Grabarczyk, P ^a   Kryczka, W ^b   Kucharski, W ^a   Kubicka, J ^b   Zupanska B ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Regional District Hospital   (Poland)

Author keywords

AntiE2; Blood donors; Hepatitis patients; HGV

Indexed keywords

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; FEMALE; FOLLOW UP; HEPATITIS G VIRUS; HUMAN; INCIDENCE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PATHOGENICITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BIOLOGICAL MARKERS; BLOOD DONORS; FLAVIVIRIDAE; HEPATITIS ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0032704411     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00159.x     Document Type: Article

References (23)

1. Leary TP, Muerhoff AS, Simons NJ et al. Sequence and genomic organisation of GBV-C: a novel member of the Flaviviridae associated with human non A-E hepatitis. J Med Virol 1996; 48: 60-67.
2. Simons JN, Leary TP, Dawson et al. Isolation of novel virus like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
3. Linnen J, Wages J, Zhang-Keck ZY et al. Molecular cloning and disease association of hepatitis G virus: a transfusion transmissible agent. Science 1996; 271: 505-508.
4. Alter HJ, Nakkatsuji Y, Melpolder J, Wesley J, Shih JW, Kim JP. The incidence of transfusion associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
5. Haydon GH, Jarvis LM, Simpson KJ, Hayes PC, Simmonds P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral hepatitis. J Virol Hepatol 1997; 4: 45-49.
6. Infantolino D, Fabris P, Biasin MR et al. Hepatitis G virus in patients with acute hepatitis of known and unknown aetiology. J Hepatol 1997; 26 (suppl 1): C01/01.
7. Tacke M, Kiyosawa K, Stark K et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-320.
8. Thomas DL, Vlahov D, Alter HJ et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998; 177: 539-542.
9. Lefrere JJ, Loiseau P, Maury J et al. Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology. Blood 1997; 90: 3776-3780.
10. Heuft HG, Berg T, Schreier E et al. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang 1998; 74: 161-167.
11. Ross RS, Viazov S, Schmittu et al. Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world. J Med Virol 1998; 54: 103-106.
12. Okamato H, Okada S, Sugiyama Y et al. Detection of hepatitis C virus RNA by two stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60: 215-222.
13. Chomczyński P, Sacchi N. Single step method of RNA isolation by acid guanidinum thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
14. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
15. Bassit L, Kleter B, Ribeiro-dos-Santos G et al. Prevalence and sequence analysis in blood donors of Sao Paulo, Brasil. Vox Sang 1997; 74: 83-87.
16. Stark K, Bienzle U, Hess U, Engel G, Hagenscheid B, Schluter V. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men and blood donors. J Inject Dis 1996; 174: 1320-1325.
17. Lewine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol 1995; 142: 331-341.
18. Sugai Y, Nakayama H, Fukuda M et al. Infection with GB virus C in patients with chronic liver disease. J Med Virol 1997; 51: 175-179.
19. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
20. Fiordalisi G, Zanella I, Mantero G. High prevalence of GB virus-C infection in a group of Italian patients with hepatitis of uknown origin. J Infect Dis 1996; 174: 181-185.
21. Heringlake S, Osterkamp S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-1629.
22. Tameda Y, Kosaka Y, Tagawa S et al. Infection with GB virus C in patients with fulminant hepatitis. J Hepatol 1996; 25: 842-847.
23. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl Med 1996; 334: 1536-1549.